BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/29/2016 3:29:00 PM | Browse: 1083 | Download: 2545
 |
Received |
|
2015-11-10 08:28 |
|
Peer-Review Started |
|
2015-11-10 16:16 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2015-11-30 10:25 |
|
Revised |
|
2015-12-13 00:48 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-12-31 08:02 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-01-11 13:08 |
|
Articles in Press |
|
2016-01-11 13:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-03-11 12:08 |
|
Publish the Manuscript Online |
|
2016-03-29 15:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Eung Chang Lee, Seong Hoon Kim, Seung Duk Lee, Hyeongmin Park, Soon-Ae Lee and Sang-Jae Park |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Seong Hoon Kim, MD, PhD, Center for Liver Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, South Korea. kshlj@ncc.re.kr |
| Key Words |
Hepatitis B immune globulin; Hepatocellular carcinoma; Hepatitis B virus-DNA; Liver transplantation; Hepatitis B e antigen |
| Core Tip |
This is a single center analysis of the effects of high-dose hepatitis B immunoglobulin (HBIG) therapy on the recurrence of hepatocellular carcinoma and hepatitis B in hepatitis B virus (HBV)-DNA/hepatitis B e antigen (HBeAg)-positive patients after LDLT. High-dose HBIG therapy can be helpful in improving hepatocellular carcinoma recurrence-free survival in HBV-DNA/HBeAg-positive recipients who met the Milan criteria. In contrast, high-dose HBIG therapy was not effective in improving HCC recurrence-free survival in HBV-DNA/HBeAg-positive recipients who did not meet the Milan criteria. Recurrence of hepatitis B and overall survival were not affected by the HBIG dose in HBV-DNA/HBeAg-positive recipients regardless of the Milan status. |
| Publish Date |
2016-03-29 15:29 |
| Citation |
Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. World J Gastroenterol 2016; 22(14): 3803-3812
|
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i14/3803.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i14.3803 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
